-
Something wrong with this record ?
Lipoprotein Particles Interact with Membranes and Transfer Their Cargo without Receptors
B. Plochberger, T. Sych, F. Weber, J. Novacek, M. Axmann, H. Stangl, E. Sezgin
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
G0902418
Medical Research Council - United Kingdom
MR/K01577X/1
Medical Research Council - United Kingdom
MC_UU_12010
Medical Research Council - United Kingdom
MC_UU_12025
Medical Research Council - United Kingdom
Biotechnology and Biological Sciences Research Council - United Kingdom
MR/K01577X/1
Medical Research Council - United Kingdom
104924/14/Z/14
Wellcome Trust - United Kingdom
- MeSH
- Biological Transport MeSH
- Cell Membrane metabolism MeSH
- Lipid Bilayers metabolism MeSH
- Lipoproteins metabolism MeSH
- Microscopy, Atomic Force MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Lipid transfer from lipoprotein particles to cells is essential for lipid homeostasis. High-density lipoprotein (HDL) particles are mainly captured by cell membrane-associated scavenger receptor class B type 1 (SR-B1) from the bloodstream, while low-density and very-low-density lipoprotein (LDL and VLDL, respectively) particles are mostly taken up by receptor-mediated endocytosis. However, the role of the target lipid membrane itself in the transfer process has been largely neglected so far. Here, we study how lipoprotein particles (HDL, LDL, and VLDL) interact with synthetic lipid bilayers and cell-derived membranes and transfer their cargo subsequently. Employing cryo-electron microscopy, spectral imaging, and fluorescence (cross) correlation spectroscopy allowed us to observe integration of all major types of lipoprotein particles into the membrane and delivery of their cargo in a receptor-independent manner. Importantly, the biophysical properties of the target cell membranes change upon delivery of cargo. The concept of receptor-independent interaction of lipoprotein particles with membranes helps us to better understand lipoprotein particle biology and can be exploited for novel treatments of dyslipidemia diseases.
CEITEC Masaryk University University Campus Bohunice Brno 62500 Czech Republic
Johannes Kepler University Linz Institute of Biophysics Linz 4020 Austria
TU Wien Institute of Applied Physics Vienna 1040 Austria
Upper Austria University of Applied Sciences Campus Linz Linz 4020 Austria
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21011863
- 003
- CZ-PrNML
- 005
- 20210507101621.0
- 007
- ta
- 008
- 210420s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.biochem.0c00748 $2 doi
- 035 __
- $a (PubMed)33147967
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Plochberger, Birgit $u TU Wien, Institute of Applied Physics, Vienna 1040, Austria $u Johannes Kepler University Linz, Institute of Biophysics, Linz 4020, Austria $u Upper Austria University of Applied Sciences, Campus Linz, Linz 4020, Austria
- 245 10
- $a Lipoprotein Particles Interact with Membranes and Transfer Their Cargo without Receptors / $c B. Plochberger, T. Sych, F. Weber, J. Novacek, M. Axmann, H. Stangl, E. Sezgin
- 520 9_
- $a Lipid transfer from lipoprotein particles to cells is essential for lipid homeostasis. High-density lipoprotein (HDL) particles are mainly captured by cell membrane-associated scavenger receptor class B type 1 (SR-B1) from the bloodstream, while low-density and very-low-density lipoprotein (LDL and VLDL, respectively) particles are mostly taken up by receptor-mediated endocytosis. However, the role of the target lipid membrane itself in the transfer process has been largely neglected so far. Here, we study how lipoprotein particles (HDL, LDL, and VLDL) interact with synthetic lipid bilayers and cell-derived membranes and transfer their cargo subsequently. Employing cryo-electron microscopy, spectral imaging, and fluorescence (cross) correlation spectroscopy allowed us to observe integration of all major types of lipoprotein particles into the membrane and delivery of their cargo in a receptor-independent manner. Importantly, the biophysical properties of the target cell membranes change upon delivery of cargo. The concept of receptor-independent interaction of lipoprotein particles with membranes helps us to better understand lipoprotein particle biology and can be exploited for novel treatments of dyslipidemia diseases.
- 650 _2
- $a biologický transport $7 D001692
- 650 _2
- $a buněčná membrána $x metabolismus $7 D002462
- 650 _2
- $a lipidové dvojvrstvy $x metabolismus $7 D008051
- 650 _2
- $a lipoproteiny $x metabolismus $7 D008074
- 650 _2
- $a mikroskopie atomárních sil $7 D018625
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Sych, Taras $u Science for Life Laboratory, Department of Women's and Children's Health, Karolinska Institutet, 17165 Solna, Sweden
- 700 1_
- $a Weber, Florian $u Upper Austria University of Applied Sciences, Campus Linz, Linz 4020, Austria $u Science for Life Laboratory, Department of Women's and Children's Health, Karolinska Institutet, 17165 Solna, Sweden
- 700 1_
- $a Novacek, Jiri $u CEITEC, Masaryk University, University Campus Bohunice, Brno 62500, Czech Republic
- 700 1_
- $a Axmann, Markus $u Medical University of Vienna, Center for Pathobiochemistry and Genetics, Institute of Medical Chemistry, Vienna 1090, Austria
- 700 1_
- $a Stangl, Herbert $u Medical University of Vienna, Center for Pathobiochemistry and Genetics, Institute of Medical Chemistry, Vienna 1090, Austria
- 700 1_
- $a Sezgin, Erdinc $u Science for Life Laboratory, Department of Women's and Children's Health, Karolinska Institutet, 17165 Solna, Sweden $u MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, U.K
- 773 0_
- $w MED00009310 $t Biochemistry $x 1520-4995 $g Roč. 59, č. 45 (2020), s. 4421-4428
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33147967 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507101621 $b ABA008
- 999 __
- $a ok $b bmc $g 1650284 $s 1132242
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 59 $c 45 $d 4421-4428 $e 20201104 $i 1520-4995 $m Biochemistry (Easton) $n Biochemistry $x MED00009310
- GRA __
- $a G0902418 $p Medical Research Council $2 United Kingdom
- GRA __
- $a MR/K01577X/1 $p Medical Research Council $2 United Kingdom
- GRA __
- $a MC_UU_12010 $p Medical Research Council $2 United Kingdom
- GRA __
- $a MC_UU_12025 $p Medical Research Council $2 United Kingdom
- GRA __
- $p Biotechnology and Biological Sciences Research Council $2 United Kingdom
- GRA __
- $a MR/K01577X/1 $p Medical Research Council $2 United Kingdom
- GRA __
- $a 104924/14/Z/14 $p Wellcome Trust $2 United Kingdom
- LZP __
- $a Pubmed-20210420